A pilot study to determine the test characteristics of serum soluble FMS-like tyrosine kinase in control patients, patients with chronic hypertension, patients with gestational hypertension, and preeclamptic patients.

***Note: Comments about this teaching resource, its content, and your thoughts can be made on this website (by registered users) or on Facebook (all users).

Estimated Time to View: 35 minutes
Target Audience: Fellows, Faculty
Title: Diagnostic Utility of solube FMS-like tyrosine kinase 1 and soluble endoglin in hypertensive diseases of pregnancy
Citation: American Journal of Obstetrics and Gynecology 2007, Volume 197, pp. e1-28.e6
Date Created: 2007
Revisions: None Indicated
Disclaimers: None
Resource Type: Text
Recommend to a Colleague/Friend

sflt-table2 sflt-abstract1

Transparent Peer Review

GD Star Rating
To learn more about our 6-point transparent peer review system, click here



More in General Nephrology, Pregnancy (46 of 212 articles)